Skip to main content

Articles

Page 23 of 41

  1. Diabetes is a serious chronic disease. Medical treatment and good psychosocial support are needed to cope with acute and long-term effects of diabetes. Self-management is a large part of diabetes management, w...

    Authors: Elisabet Nerpin, Eva Toft, Johan Fischier, Anna Lindholm-Olinder and Janeth Leksell
    Citation: BMC Endocrine Disorders 2020 20:137
  2. Previous studies have shown the negative impact of sleep disturbances, specifically insomnia symptoms, on glucose metabolism for people with type 2 diabetes (T2D). People with insomnia symptoms are at risk of ...

    Authors: Mohammed M. Alshehri, Shaima A. Alothman, Aqeel M. Alenazi, Jason L. Rucker, Milind A. Phadnis, John M. Miles, Catherine F. Siengsukon and Patricia M. Kluding
    Citation: BMC Endocrine Disorders 2020 20:136
  3. Euthyroid sick syndrome (ESS) frequently arises in children admitted with diabetic ketoacidosis/diabetic ketosis (DKA/DK). This study evaluates the interplay of various metabolic factors with occurrence of der...

    Authors: Peng Shao, Shujuan Guo, Guimei Li, Daogang Qin, Sen Li and Ying Luan
    Citation: BMC Endocrine Disorders 2020 20:135
  4. Diabetic foot ulcers (DFU) are associated with high morbidity and mortality globally. Mortality in patients hospitalized for DFU in Nigeria is unacceptably high. This study was undertaken to determine factors ...

    Authors: Olufunmilayo O. Adeleye, Ejiofor T. Ugwu, Ibrahim D. Gezawa, Innocent Okpe, Ignatius Ezeani and Marcelina Enamino
    Citation: BMC Endocrine Disorders 2020 20:134
  5. Graves’ disease is the commonest cause of thyrotoxicosis whilst thyrotropin (TSH)-producing pituitary adenomas (thyrotropinomas, TSHomas) are very rare and account for just 1–2% of all pituitary adenomas. Coex...

    Authors: Mark Quinn, Waiel Bashari, Diarmuid Smith, Mark Gurnell and Amar Agha
    Citation: BMC Endocrine Disorders 2020 20:133
  6. Immune checkpoint inhibitors (ICIs) can induce immune-related adverse events (irAEs) including thyroid dysfunction. There are only a few reports on Graves’ disease induced by ICIs. We report a case of new-onse...

    Authors: Hiroshi Yamada, Fumitaka Okajima, Takeshi Onda, Shunji Fujimori, Naoya Emoto and Hitoshi Sugihara
    Citation: BMC Endocrine Disorders 2020 20:132
  7. Sympathetic activity and insulin resistance have recently been linked with chronic tendon and musculoskeletal pain. Polycystic ovarian syndrome is linked with insulin resistance and increased sympathetic drive...

    Authors: Jacob Jewson, Elisabeth Lambert, Carolina Sari, Eveline Jona, Soulmaz Shorakae, Gavin Lambert and Jamie Gaida
    Citation: BMC Endocrine Disorders 2020 20:131
  8. Although important achievements have been done in type 2 diabetes mellitus (T2D) treatment and glycemic control, new strategies may take advantage of non-pharmacological approaches and of other potential deter...

    Authors: Rubén Silva-Tinoco, Teresa Cuatecontzi-Xochitiotzi, Viridiana De la Torre-Saldaña, Enrique León-García, Javier Serna-Alvarado, Arturo Orea-Tejeda, Lilia Castillo-Martínez, Juan G. Gay, David Cantú-de-León and Diddier Prada
    Citation: BMC Endocrine Disorders 2020 20:130
  9. Diabetic foot is an underestimated and redoubtable diabetes complication. The aims of our study were to assess diabetic foot ulcer risk factors according to International Working Group on the Diabetic Foot (IW...

    Authors: B. Zantour, S. Bouchareb, Z. El Ati, F. Boubaker, W. Alaya, W. Kossomtini and M. H. Sfar
    Citation: BMC Endocrine Disorders 2020 20:128
  10. Fulminant type 1 diabetes mellitus (FT1D) is a newly established subtype of type 1 diabetes. Its etiology has not been fully elucidated. Several cases with FT1D have exhibited pancreatitis or myocarditis.

    Authors: Fujiko Egashira, Midori Kawashima, Ai Morikawa, Minami Kosuda, Hisamitsu Ishihara and Kentaro Watanabe
    Citation: BMC Endocrine Disorders 2020 20:127
  11. Acromegaly is a rare, chronic and severe disease. Drug therapy including somatostatin analogues (SAs), dopamine receptor agonists and growth hormone receptor antagonists (pegvisomant, PEG) are commonly used to...

    Authors: Lingyun Ma, Daohuang Luo, Ting Yang, Songtao Wu, Min Li, Chaoyang Chen, Shuang Zhou, Lingyue Ma, Ye Wu, Ying Zhou and Yimin Cui
    Citation: BMC Endocrine Disorders 2020 20:126
  12. Diabetes is a leading cause of Medicare spending; predicting which individuals are likely to be costly is essential for targeting interventions. Current approaches generally focus on composite measures, short ...

    Authors: Julie C. Lauffenburger, Mufaddal Mahesri and Niteesh K. Choudhry
    Citation: BMC Endocrine Disorders 2020 20:125
  13. Modern imaging plays a central role in the care of obese patients, and there is an integral focus on its use and accessibility in individuals who have alterations of various in various organs. The objective in...

    Authors: Alejandra Martínez Coria, Norma Angélica Estrada-Cruz, María Inés Pérez Ordoñez, Daniel H. Montes-Cortes and Leticia Manuel-Apolinar
    Citation: BMC Endocrine Disorders 2020 20:124
  14. Type 1 Diabetes (T1D) is a T cell-mediated autoimmune disorder caused by the destruction of insulin-secreting cells. B7-H3 (CD276) plays a vital role in T cell response. However, B7-H3 expression and its clini...

    Authors: Sisi Ding, Yimei Shan, Lili Sun, Sicheng Li, Rong Jiang, Xin Chang, Ziyi Huang, Jing Sun, Cuiping Liu, Chen Fang and Xueguang Zhang
    Citation: BMC Endocrine Disorders 2020 20:123
  15. The prevalence of type 2 diabetes mellitus (T2DM) is expected to increase from 7.7% in 2017 to 8.4% in 2045 worldwide. Diabetes complications contribute to morbidity and mortality. To evaluate whether the diab...

    Authors: Hyunju Yoo, Eunjung Choo and Sukhyang Lee
    Citation: BMC Endocrine Disorders 2020 20:122
  16. The association between the polymorphisms in the vitamin D receptor (VDR) gene and the risk of type 1 diabetes mellitus (T1DM) has been evaluated in several studies. However, the findings were inconclusive. Thus,...

    Authors: Na Zhai, Ramtin Bidares, Masoud Hassanzadeh Makoui, Saeed Aslani, Payam Mohammadi, Bahman Razi, Danyal Imani, Mohammad Yazdchi and Haleh Mikaeili
    Citation: BMC Endocrine Disorders 2020 20:121
  17. Basedow’s disease and Hashimoto’s thyroiditis are autoimmune thyroid disorders and usually diagnosed with elevation of serum autoimmune antibodies. Thyrotropin receptor antibodies (TRAb) and/or thyroid-stimula...

    Authors: Megumi Horiya, Takatoshi Anno, Fumiko Kawasaki, Yuichiro Iwamoto, Shintaro Irie, Yasumasa Monobe, Koichi Tomoda, Kohei Kaku, Shuhei Nakanishi and Hideaki Kaneto
    Citation: BMC Endocrine Disorders 2020 20:120
  18. The growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis is critical for the regulation of children’s growth and development. Serum IGF-1 concentrations are usually low in individuals with idiopathic sh...

    Authors: Qianqian Zhao, Mei Zhang, Baolan Ji, Yuntian Chu, Hui Pan, Wenhua Yan and Bo Ban
    Citation: BMC Endocrine Disorders 2020 20:119
  19. The escalating prevalence of adrenal incidentaloma (AI) has been associated with the improvement of radiologic techniques and widespread imaging in aging population. It is currently unclear whether patients wi...

    Authors: Ana Podbregar, Andrej Janez, Katja Goricar and Mojca Jensterle
    Citation: BMC Endocrine Disorders 2020 20:118
  20. Acromegaly patients managed on Somatostatin receptor ligands (SRLs), the most common first-line pharmacotherapy for acromegaly, may still experience acromegaly symptoms such as headache, sweating, fatigue, sof...

    Authors: Eliza B. Geer, Jill Sisco, Daphne T. Adelman, William H. Ludlam, Asi Haviv, Shuqian Liu, Susan D. Mathias, Dana Gelbaum and Lizheng Shi
    Citation: BMC Endocrine Disorders 2020 20:117
  21. Cushing’s syndrome has been described as a complex endocrine disorder characterized with high cortisol concentration. Correct and early diagnosis of Cushing’s syndrome is challenging. According to the latest g...

    Authors: Huiwen Tan, Dawei Chen, Yerong Yu, Kai Yu, Weiming He, Bowen Cai, Su Jiang, Ying Tang, Nanwei Tong and Zhenmei An
    Citation: BMC Endocrine Disorders 2020 20:116
  22. Primary aldosteronism (PA) increases the risk of cardiovascular morbidity, including stroke, coronary artery disease, atrial fibrillation, and heart failure. The relationship between primary aldosteronism and ...

    Authors: Ying Zhang, Fang Luo, Peng Fan, Xu Meng, Kunqi Yang and Xianliang Zhou
    Citation: BMC Endocrine Disorders 2020 20:115
  23. We investigated whether the contralateral suppression index in aldosterone-producing adrenal adenoma could be used as a diagnostic criterion when catheterization in either right or left adrenal vein fails or w...

    Authors: Jeongmin Lee, Borami Kang, Jeonghoon Ha, Min-Hee Kim, Byungil Choi, Tae-Ho Hong, Moo IL Kang and Dong-Jun Lim
    Citation: BMC Endocrine Disorders 2020 20:114
  24. Colorectal cancer (CRC), which is related with insulin resistance, is a one of the most common cancers. Triglyceride-glucose index (TyG index) was made for a marker of insulin resistance. We conducted the inve...

    Authors: Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, Akihiro Obora, Takao Kojima and Michiaki Fukui
    Citation: BMC Endocrine Disorders 2020 20:113
  25. Albuminuria is the early manifestation of the pathogenesis of diabetic nephropathy (DN). The current study was to investigate the relationship of pulmonary function with albuminuria in type 2 diabetic patients...

    Authors: Yun-Yun He, Zhe Chen, Xiang-Yang Fang, Jing Chang, Yong Lu and Xiao-Juan Wang
    Citation: BMC Endocrine Disorders 2020 20:112
  26. Marital status proves to be an independent prognostic factor in a variety of cancers. However, its prognostic impact on gastric neuroendocrine neoplasms (G-NEN) has not been investigated.

    Authors: Yu-Jie Zhou, Xiao-Fan Lu, Kenneth I. Zheng, Qi-Wen Wang, Jin-Nan Chen, Qing-Wei Zhang, Fang-Rong Yan and Xiao-Bo Li
    Citation: BMC Endocrine Disorders 2020 20:111
  27. Some studies have shown that a high level of bilirubin is a protective factor against metabolic syndrome (MS), while a high level of transaminase is a risk factor for MS. However, the existing results are inco...

    Authors: Hao Hao, Heng Guo, Ru-lin Ma, Yi-zhong Yan, Yun-hua Hu, Jiao-long Ma, Xiang-hui Zhang, Xin-ping Wang, Kui Wang, La-ti Mu, Yan-peng Song, Jing-yu Zhang, Jia He and Shu-xia Guo
    Citation: BMC Endocrine Disorders 2020 20:110
  28. Type 2 diabetes mellitus (T2D) is the most frequent type of diabetes. It has a multifactorial etiology, affecting millions of people worldwide. Ghrelin gene (GHRL) encodes the ghrelin peptide, which promotes food...

    Authors: Edgar Alfonso Rivera-León, Mara Anaís Llamas-Covarrubias, Sergio Sánchez-Enríquez, Erika Martínez-López, Mercedes González-Hita and Iris Monserrat Llamas-Covarrubias
    Citation: BMC Endocrine Disorders 2020 20:109
  29. Zonulin is a biomarker of impaired intestinal permeability, which has been associated with various disorders. The primary aim was to study serum zonulin (s-zonulin) in individuals with morbid obesity before an...

    Authors: Martin Aasbrenn, Stian Lydersen and Per G Farup
    Citation: BMC Endocrine Disorders 2020 20:108
  30. Some previous studies have reported inconsistent results on the association between alcohol intake and diabetic retinopathy (DR) risk. This study aimed to evaluate the potential effects of alcohol intake on su...

    Authors: Chen Chen, Zhaojun Sun, Weigang Xu, Jun Tan, Dan Li, Yiting Wu, Ting Zheng and Derong Peng
    Citation: BMC Endocrine Disorders 2020 20:106
  31. Statins are the first-line pharmaceutical agent in the management of hypercholesterolemia and cardiovascular (CV) risk reduction, and the most commonly prescribed class of drugs worldwide. Studies describing C...

    Authors: Ezra S. Hornik, Anne E. Altman-Merino, Andrew W. Koefoed, Kayla M. Meyer, Isabella B. Stone, Jessica A. Green, Gordon H. Williams, Gail K. Adler and Jonathan S. Williams
    Citation: BMC Endocrine Disorders 2020 20:105
  32. Recently, CaMKIV has been identified as a potential regulator of skeletal muscle glucose metabolism, it can also affect insulin gene expression in pancreas. However, its effects on adipose insulin resistance h...

    Authors: Jiali Liu, Ruihua Yang, Hao Meng, Ting Zhou and Qian He
    Citation: BMC Endocrine Disorders 2020 20:104
  33. To evaluate the association between high-sensitivity C-reactive protein (hsCRP) and erythrocyte sedimentation rate (ESR), and diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM).

    Authors: Shizhe Guo, Meng Wang, Yifei Yu, Yeping Yang, Fangfang Zeng, Fei Sun, Qin Li, Min He, Yiming Li, Jie Wen, Wei Gong and Zhaoyun Zhang
    Citation: BMC Endocrine Disorders 2020 20:103
  34. The associations between sociodemographic factors and HbA1c variability in type 2 diabetes are not yet established. Examining group differences in HbA1c variability may help identify patient characteristics re...

    Authors: Emelia Mellergård, Per Johnsson and Frida Eek
    Citation: BMC Endocrine Disorders 2020 20:102
  35. Anti-Müllerian hormone (AMH) is now considered the best serum biomarker of ovarian reserve, while basal sex hormones are classic markers used for assessing ovarian reserve. The interaction between AMH and sex ...

    Authors: Ping-Ping Lv, Min Jin, Jin-Peng Rao, Jian Chen, Li-Quan Wang, Chang-Chang Huang, Song-Qing Yang, Qiu-Ping Yao, Lei Feng, Jin-Ming Shen and Chun Feng
    Citation: BMC Endocrine Disorders 2020 20:101
  36. The association between subclinical hypothyroidism (SCH) and metabolic risk factors in the general health examination-based population has been widely explored. However, the results have been inconclusive. Add...

    Authors: Li Jiang, Jinman Du, Weizhu Wu, Jianjiang Fang, Jufang Wang and Jinhua Ding
    Citation: BMC Endocrine Disorders 2020 20:100
  37. Subclinical diabetic cardiomyopathy (DCM) occurs frequently in asymptomatic subjects with Type 2 diabetes mellitus (T2DM). The direct association between the immune system and DCM with effective biomarkers has...

    Authors: Xiaoli Huang, Zihan Qin, Min Xu, Feifei Zhang, Xiaohong Jiang, Fei Hua and Lichan Tao
    Citation: BMC Endocrine Disorders 2020 20:99
  38. With the obesity epidemic reaching crisis levels, there has been attention around those who may be resilient to the effects of obesity, termed metabolically healthy obesity (MHO), who initially present without...

    Authors: A. Vusirikala, T. Thomas, N. Bhala, A. A. Tahrani, G. N. Thomas and K. Nirantharakumar
    Citation: BMC Endocrine Disorders 2020 20:96
  39. A family history of diabetes and family members’ experiences with diabetes may influence individuals’ beliefs and expectations about their own diabetes. No qualitative studies have explored the relationship be...

    Authors: Amy T. Cunningham, Alexzandra T. Gentsch, Amanda M. B. Doty, Geoffrey Mills, Marianna LaNoue, Brendan G. Carr, Judd E. Hollander and Kristin L. Rising
    Citation: BMC Endocrine Disorders 2020 20:95
  40. Caloric restriction is an effective way to treat Type 2 diabetes (T2D). However, chronic and severe restriction of food intake is difficult to sustain and is known to promote slower metabolism. Intermittent an...

    Authors: Elske L. van den Burg, Marjolein P. Schoonakker, Petra G. van Peet, M. Elske. van den Akker-van Marle, Ko Willems van Dijk, Valter D. Longo, Hildo J. Lamb, Mattijs E. Numans and Hanno Pijl
    Citation: BMC Endocrine Disorders 2020 20:94

    The Correction to this article has been published in BMC Endocrine Disorders 2020 20:164

  41. Takotsubo syndrome is an uncommon, acute, and reversible cardiomyopathy that occurs primarily in postmenopausal females. The clinical presentation of the syndrome resembles acute coronary syndrome, but coronar...

    Authors: Min Chen, Tong Zhao, Guoping Chen and Shenjiang Hu
    Citation: BMC Endocrine Disorders 2020 20:93
  42. The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type 1 diabetes varies internationally and is mainly determined by the national healthcare reimbursement systems. The aim of ...

    Authors: Katarzyna Anna Gajewska, Kathleen Bennett, Regien Biesma and Seamus Sreenan
    Citation: BMC Endocrine Disorders 2020 20:92
  43. One of most important concerns of postmenopausal women is obesity. The relationships between menstruation status and obesity phenotypes are unclear. This study aimed to assess the associations between menstrua...

    Authors: Xueyu Chen, Hui Xi, Long Ji, Weihua Liu, Fengxue Shi, Yanru Chen, Xiaohui Wang, Wenran Zhang, Xinxia Sui, Xiaojun Wang, Haitao Zhang, Huamin Liu and Dong Li
    Citation: BMC Endocrine Disorders 2020 20:91
  44. It is clinically emergent to further understand the pathological mechanism to advance therapeutic strategy for endocrine tumors. A high amount of secretory protein with tumorigenic triggers are thought to indu...

    Authors: Shuhei Morita, Ken Takeshima, Hiroyuki Ariyasu, Yasushi Furukawa, Shohei Kishimoto, Tomoya Tsuji, Shinsuke Uraki, Hiroyuki Mishima, Akira Kinoshita, Yuichi Takahashi, Hidefumi Inaba, Hiroshi Iwakura, Hiroto Furuta, Masahiro Nishi, Asako Doi, Shin-ichi Murata…
    Citation: BMC Endocrine Disorders 2020 20:90
  45. After years of decline, the rate of amputations was reported to increase by 50% in the U.S. population between 2009 and 2015. Few studies have examined the most recent trends in hospitalized diabetic foot ulce...

    Authors: Yotsapon Thewjitcharoen, Jeeraphan Sripatpong, Sirinate Krittiyawong, Sriurai Porramatikul, Taweesak Srikummoon, Somkiet Mahaudomporn, Siriwan Butadej, Soontaree Nakasatien and Thep Himathongkam
    Citation: BMC Endocrine Disorders 2020 20:89
  46. This study aimed to measure the effect of diabetes education using the novel method of “diabetes conversation map (DCM)” as compared to routine counselling (RC) on diabetes management self-efficacy (DMSE) amon...

    Authors: Rubina Qasim, Sarfaraz Masih, Mohammad Tahir Yousafzai, Hakim shah, Abdul Manan, Yousaf Shah, Muhammad Yaqoob, Abida Razzaq, Ajmal Khan and Atiya Rahman Khan Rohilla
    Citation: BMC Endocrine Disorders 2020 20:88

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.8
    5-year Journal Impact Factor: 3.1
    Source Normalized Impact per Paper (SNIP): 0.914
    SCImago Journal Rank (SJR): 0.789

    Speed 2023
    Submission to first editorial decision (median days): 23
    Submission to acceptance (median days): 215

    Usage 2023
    Downloads: 1,801,905
    Altmetric mentions: 2,575

Sign up for article alerts and news from this journal